T cells and macrophages responding to oxidative damage cooperate in pathogenesis of a mouse model of age-related macular degeneration

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Cruz Guilloty, Fernando ^a,b,e   Saeed, Ali M ^a   Duffort, Stephanie ^a   Cano, Marisol ^c   Ebrahimi, Katayoon B ^c   Ballmick, Asha ^a   Tan, Yaohong ^a   Wang, Hua ^d   Laird, James M ^d   Salomon, Robert G ^d   Handa, James T ^c   Perez, Victor L ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e Immucor Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYETHYLPYRROLE; CYCLOSPORIN A; GAMMA INTERFERON; INTERLEUKIN 17; LIPID PEROXIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; RAPAMYCIN; UNCLASSIFIED DRUG; CYCLOSPORIN; INTERLEUKIN 7; PYRROLE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; IL 12 GENE; IL 1B GENE; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INOS GENE; LYMPHOCYTE DIFFERENTIATION; M1 MACROPHAGE; MACROPHAGE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PATHOGENESIS; PIGMENT EPITHELIUM; POLARIZATION; RETINA MACULA AGE RELATED DEGENERATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TNF ALPHA GENE; ANIMAL; BIOSYNTHESIS; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; HUMAN; IMMUNIZATION; IMMUNOLOGY; MACULAR DEGENERATION; METABOLISM; RETINAL PIGMENT EPITHELIUM; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CYCLOSPORINE; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNIZATION; INTERFERON-GAMMA; INTERLEUKIN-7; MACROPHAGES; MACULAR DEGENERATION; MALE; MICE; OXIDATIVE STRESS; PYRROLES; RETINAL PIGMENT EPITHELIUM; SIROLIMUS; T-LYMPHOCYTES;

EID: 84896111012     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088201     Document Type: Article

References (60)

1. Bird AC (2010) Therapeutic targets in age-related macular disease. J Clin Invest 120: 3033-3041.
2. Coleman HR, Chan CC, Ferris FL 3rd, Chew EY (2008) Age-related macular degeneration. Lancet 372: 1835-1845.
3. Buschini E, Piras A, Nuzzi R, Vercelli A (2011) Age related macular degeneration and drusen: neuroinflammation in the retina. Prog Neurobiol 95: 14-25.
4. Bressler SB, Maguire MG, Bressler NM, Fine SL (1990) Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. The Macular Photocoagulation Study Group. Arch Ophthalmol 108: 1442-1447. (Pubitemid 20344701)
5. Sarks SH, Van Driel D, Maxwell L, Killingsworth M (1980) Softening of drusen and subretinal neovascularization. Trans Ophthalmol Soc U K 100: 414-422. (Pubitemid 11088109)
6. Ambati J, Fowler BJ (2012) Mechanisms of age-related macular degeneration. Neuron 75: 26-39.
7. Ambati J, Atkinson JP, Gelfand BD (2013) Immunology of age-related macular degeneration. Nat Rev Immunol 13: 438-451.
8. Whitcup SM, Sodhi A, Atkinson JP, Holers VM, Sinha D, et al. (2013) The role of the immune response in age-related macular degeneration. Int J Inflam 2013: 348092.
9. Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, et al. (2002) Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci U S A 99: 14682-14687. (Pubitemid 35334544)
10. Edwards AO, Ritter R 3rd, Abel KJ, Manning A, Panhuysen C, et al. (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308: 421-424. (Pubitemid 40530082)
11. Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, et al. (2006) Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 38: 458-462.
12. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, et al. (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102: 7227-7232. (Pubitemid 40696361)
13. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, et al. (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science 308: 419-421. (Pubitemid 40530081)
14. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, et al. (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308: 385-389. (Pubitemid 40530070)
15. Yates JR, Sepp T, Matharu BK, Khan JC, Thurlby DA, et al. (2007) Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med 357: 553-561. (Pubitemid 47236280)
16. Nussenblatt RB, Ferris F 3rd (2007) Age-related macular degeneration and the immune response: implications for therapy. Am J Ophthalmol 144: 618-626.
17. Nussenblatt RB, Liu B, Li Z (2009) Age-related macular degeneration: an immunologically driven disease. Curr Opin Investig Drugs 10: 434-442.
18. Parmeggiani F, Romano MR, Costagliola C, Semeraro F, Incorvaia C, et al. (2012) Mechanism of inflammation in age-related macular degeneration. Mediators Inflamm 2012: 546786.
19. Tuo J, Grob S, Zhang K, Chan CC (2012) Genetics of immunological and inflammatory components in age-related macular degeneration. Ocul Immunol Inflamm 20: 27-36.
20. Iwasaki A, Medzhitov R (2010) Regulation of adaptive immunity by the innate immune system. Science 327: 291-295.
21. Palm NW, Medzhitov R (2009) Pattern recognition receptors and control of adaptive immunity. Immunol Rev 227: 221-233.
22. Lichtman AH, Binder CJ, Tsimikas S, Witztum JL (2013) Adaptive immunity in atherogenesis: new insights and therapeutic approaches. J Clin Invest 123: 27-36.
23. Ambati J, Anand A, Fernandez S, Sakurai E, Lynn BC, et al. (2003) An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2- deficient mice. Nat Med 9: 1390-1397. (Pubitemid 37466188)
24. Apte RS, Richter J, Herndon J, Ferguson TA (2006) Macrophages inhibit neovascularization in a murine model of age-related macular degeneration. PLoS Med 3: e310.
25. Cousins SW, Espinosa-Heidmann DG, Csaky KG (2004) Monocyte activation in patients with age-related macular degeneration: a biomarker of risk for choroidal neovascularization? Arch Ophthalmol 122: 1013-1018. (Pubitemid 39037966)
26. Cruz-Guilloty F, Saeed AM, Echegaray JJ, Duffort S, Ballmick A, et al. (2013) Infiltration of proinflammatory m1 macrophages into the outer retina precedes damage in a mouse model of age-related macular degeneration. Int J Inflam 2013: 503725.
27. Kelly J, Ali Khan A, Yin J, Ferguson TA, Apte RS (2007) Senescence regulates macrophage activation and angiogenic fate at sites of tissue injury in mice. J Clin Invest 117: 3421-3426. (Pubitemid 350096997)
28. Sene A, Khan AA, Cox D, Nakamura RE, Santeford A, et al. (2013) Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration. Cell Metab 17: 549-561.
29. Weismann D, Hartvigsen K, Lauer N, Bennett KL, Scholl HP, et al. (2011) Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature 478: 76-81.
30. Biswas SK, Mantovani A (2010) Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 11: 889-896.
31. Sica A, Mantovani A (2012) Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122: 787-795.
32. Kaech SM, Cui W (2012) Transcriptional control of effector and memory CD8+ T cell differentiation. Nat Rev Immunol 12: 749-761.
33. Yamane H, Paul WE (2012) Cytokines of the gamma(c) family control CD4+ T cell differentiation and function. Nat Immunol 13: 1037-1044.
34. Liu B, Wei L, Meyerle C, Tuo J, Sen HN, et al. (2011) Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration. J Transl Med 9: 1-12.
35. Faber C, Singh A, Kruger Falk M, Juel HB, Sorensen TL, et al. (2013) Age-Related Macular Degeneration Is Associated with Increased Proportion of CD56 T Cells in Peripheral Blood. Ophthalmology.
36. Cruz-Guilloty F, Perez VL (2011) Molecular medicine: Defence against oxidative damage. Nature 478: 42-43.
37. Handa JT (2012) How does the macula protect itself from oxidative stress? Mol Aspects Med 33: 418-435.
38. Gu X, Meer SG, Miyagi M, Rayborn ME, Hollyfield JG, et al. (2003) Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. J Biol Chem 278: 42027-42035. (Pubitemid 37310467)
39. Gu J, Pauer GJ, Yue X, Narendra U, Sturgill GM, et al. (2010) Proteomic and Genomic Biomarkers for Age-Related Macular Degeneration. Adv Exp Med Biol 664: 411-417.
40. Hollyfield JG, Bonilha VL, Rayborn ME, Yang X, Shadrach KG, et al. (2008) Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med 14: 194-198. (Pubitemid 351214555)
41. Hollyfield JG, Perez VL, Salomon RG (2010) A hapten generated from an oxidation fragment of docosahexaenoic acid is sufficient to initiate age-related macular degeneration. Mol Neurobiol 41: 290-298.
42. Lu L, Gu X, Hong L, Laird J, Jaffe K, et al. (2009) Synthesis and structural characterization of carboxyethylpyrrole-modified proteins: mediators of age-related macular degeneration. Bioorg Med Chem 17: 7548-7561.
43. Kadl A, Meher AK, Sharma PR, Lee MY, Doran AC, et al. (2010) Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2. Circ Res 107: 737-746.
44. Pipkin ME, Sacks JA, Cruz-Guilloty F, Lichtenheld MG, Bevan MJ, et al. (2010) Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity 32: 79-90.
45. Barshes NR, Goodpastor SE, Goss JA (2004) Pharmacologic immunosuppression. Front Biosci 9: 411-420. (Pubitemid 38925470)
46. Cherepanoff S, McMenamin P, Gillies MC, Kettle E, Sarks SH (2010) Bruch's membrane and choroidal macrophages in early and advanced age-related macular degeneration. Br J Ophthalmol 94: 918-925.
47. Cao X, Shen D, Patel MM, Tuo J, Johnson TM, et al. (2011) Macrophage polarization in the maculae of age-related macular degeneration: a pilot study. Pathol Int 61: 528-535.
48. Yuan C, Chen H, Anderson RE, Kuwata O, Ebrey TG (1998) The unique lipid composition of gecko (Gekko Gekko) photoreceptor outer segment membranes. Comp Biochem Physiol B Biochem Mol Biol 120: 785-789. (Pubitemid 29027973)
49. West XZ, Malinin NL, Merkulova AA, Tischenko M, Kerr BA, et al. (2010) Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature 467: 972-976.
50. Doyle SL, Campbell M, Ozaki E, Salomon RG, Mori A, et al. (2012) NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components. Nat Med 18: 791-798.
51. Morohoshi K, Goodwin AM, Ohbayashi M, Ono SJ (2009) Autoimmunity in retinal degeneration: autoimmune retinopathy and age-related macular degeneration. J Autoimmun 33: 247-254.
52. Morohoshi K, Ohbayashi M, Patel N, Chong V, Bird AC, et al. (2012) Identification of anti-retinal antibodies in patients with age-related macular degeneration. Exp Mol Pathol 93: 193-199.
53. Morohoshi K, Patel N, Ohbayashi M, Chong V, Grossniklaus HE, et al. (2012) Serum autoantibody biomarkers for age-related macular degeneration and possible regulators of neovascularization. Exp Mol Pathol 92: 64-73.
54. Binder CJ, Hartvigsen K, Chang MK, Miller M, Broide D, et al. (2004) IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J Clin Invest 114: 427-437. (Pubitemid 39071615)
55. Hermansson A, Ketelhuth DF, Strodthoff D, Wurm M, Hansson EM, et al. (2010) Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis. J Exp Med 207: 1081-1093.
56. Lugo-Villarino G, Maldonado-Lopez R, Possemato R, Penaranda C, Glimcher LH (2003) T-bet is required for optimal production of IFN-gamma and antigen-specific T cell activation by dendritic cells. Proc Natl Acad Sci U S A 100: 7749-7754. (Pubitemid 36760041)
57. Mitsdoerffer M, Lee Y, Jager A, Kim HJ, Korn T, et al. (2010) Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc Natl Acad Sci U S A 107: 14292-14297.
58. Wei L, Liu B, Tuo J, Shen D, Chen P, et al. (2012) Hypomethylation of the IL17RC promoter associates with age-related macular degeneration. Cell Rep 2: 1151-1158.
59. Luger D, Silver PB, Tang J, Cua D, Chen Z, et al. (2008) Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 205: 799-810. (Pubitemid 351549879)
60. Zhao C, Yasumura D, Li X, Matthes M, Lloyd M, et al. (2013) mTOR-mediated dedifferentiation of the retinal pigment epithelium initiates photoreceptor degeneration in mice. J Clin Invest. 121(1): 369-383.